Blog

4 posts

New (painless) Injection Technology; Low-priced and Incredibly Easy to Use

The purpose of our single-shot, pre-filled, pre-measured device is simple: to deliver a drug to the body of the patient effectively and painlessly. Our revolutionary technology, the PKA SoftTouch Micro-Needle, achieves this with every single application. About the size of a cork, our device, when properly applied to the skin of an animal or human, will result in a 95% to 97% delivery of the drug into the skin. This achieves effective delivery of the drug into the body with every use, which is a Health Canada and USFDA requirement.

Both Canadian and American governments require drug doses to be marked on the device. To enhance identification of the drug and dosage, our caps are colour coded and referenced to the inside of the box lid containing the device.

The device needle being 1.5mm long delivers the drug between the epidermis and dermis, between these skin layers, allowing a patient to painlessly inject almost anywhere there is skin on the body of an animal or human. This exceptional feature of our micro-needle has been tested and proven in two clinical trials; at the University of Guelph on dogs and at St. Joseph Hospital in Toronto on humans.

The device was designed to be used effortlessly in one hand through minimizing the hand operation by a single movement of compressing a spring. The device is incredibly easy to use and was designed to apply the same pressure one would use to operate a syringe. The simplicity of the technology allows patients from the age of 8 to 80 years old to easily administer medications using our device.

Another impressive feature of the PKA SoftTouch Micro-Needle is that it combines a syringe and vial of drug into one device. Since most of the components are made of injection moulded plastic parts, they can be made inexpensively. A few years ago, we costed the pre-filled device to be similar to a dose of drug and syringe on a volume basis. Generally, the cost is $3.00 CAN per device. As such, it is expected that the cost and ease of use coupled with the painless delivery will make the PKA SoftTouch Micro-Needle a replacement for syringes on the injectables market, interrupting the syringe market entirely.

A painless injection will be welcomed by many patients globally and our team are extremely excited to commercialize this innovative and life-changing medical device.

Equity in PKA SoftTouch will be available soon. Sign up to stay in touch with the latest news about this breakthrough technology and the opportunity to purchase shares in our company: http://eepurl.com/gN_u6H

PKA SoftTouch Corp. is a leading-edge research and development company that has created a unique, revolutionary and proprietary device; the PKA SoftTouch Micro-Needle. This revolutionary device will replace the ubiquitous syringe in drug applications for the pharmaceutical, health care and veterinary industries by offering a precise, pain-free medication delivery in a safe and effective manner.

Injections Made Easy and Pain-free!

Do you have to give yourself, your child, an elderly person, or your pet an injection regularly? Did you ever think that the words ‘easy’ and ‘pain-free’ would ever be associated with needles? 

That day has come with the PKA SoftTouch Micro-Needle. Our small ingenious device, about the size of a thumb, will bring medications like insulin, preloaded and premeasured, to people and animals suffering from chronic conditions like diabetes.

Do you have to give yourself, your child, an elderly person, or your pet an injection regularly? Did you ever think that the words ‘easy’ and ‘pain-free’ would ever be associated with needles? 

That day has come with the PKA SoftTouch Micro-Needle. Our small ingenious device, about the size of a thumb, will bring medications like insulin, preloaded and premeasured, to people and animals suffering from chronic conditions like diabetes.

Incredibly simple to use, it can be hidden in a pocket or purse due to its compact size. In one smooth move, you can inject yourself or an animal by pressing a tiny plunger that releases the micro-needle. The needle retracts after the medication enters the skin and then locks back inside the device so it can’t be used again. It’s these simple design features that will drastically reduce, if not eliminate, accidental needle sticks. 

The micro-needle is so tiny that it goes only as far as the gap between skin layers, where there are no nerve endings but instead fluid, which carries the medication rapidly into your bloodstream. It’s a breakthrough in the world of healthcare delivery and it’s protected by patents in over 21 countries, with more on the way.

No longer will people have to draw medication from a vial into an outdated syringe. No longer will people and animals have to endure the pain of an injection. No longer will people require a sharps disposal in their homes and workplaces – and say goodbye to the high cost of injection pens! Our vision is to change the way millions of people and animals’ function on a daily basis.

 Imagine taking your children for vaccinations and it becomes a tear-free, pain-free experience. Stressful doctor visits can fade from memory. If you’ve taken care of family members at home, then you know the feeling of uneasiness when our loved ones wince as we inject their skin. 

 With approximately 900,000 dogs and cats living with diabetes in homes across North America, pet owners will also appreciate the benefits that a painless injection could provide for them and their furry companions.  Animals feel pain too and once a dog or cat learns that the syringe is associated with pain, they are much harder to catch for their daily injections. 

This applies to large animals too. As our micro-needle does not resemble a syringe, animals such as cows, horses, and pigs will be more approachable for injections. Our technology was designed for safety and ease of use – to be used effortlessly in one hand. Animals won’t need to be restrained as they would for a syringe injection. 

Later this month, PKA SoftTouch Corp. is moving forward with an equity crowdfunding campaign to perform our last clinical trials in both the veterinary and human markets. To learn more, please visit pkasofttouch.com. Watch our video and subscribe for updates about your opportunity to become a shareholder of our company.

No Pain, All Gain

Our skin is composed of two layers, the epidermis, and the dermis.  The dermis contains a further two layers: the papillary and reticular dermis, and beneath this, the subcutaneous tissue composed of fatty tissue and nerves. 

There are three primary methods by which drugs may be injected: subcutaneously, intramuscularly and intradermally. The PKA SoftTouch Micro-Needle targets the skin by intradermal injection:

Let’s Take a Closer Look

Needles on syringes go over 8 millimeters deep into the fatty and muscular subcutaneous tissues and we feel pain because that’s where our nerve endings are. Conventional methods of injecting drugs also provide less direct dispersal as the drug is injected deeper and needs to permeate tissues.

The PKA SoftTouch Micro-Needle is the ONLY patented device that injects the drug directly into the skin layer. The tiny needle enters the skin only 1.5 millimeters, not deep enough to hit the nerve junctions and cause pain.

By targeting the interstitial fluid between the layers of the skin, we have proven that a shallow delivery process enhances the uptake, bioavailability and efficacy of drugs. The shallow injection into the skin allows the drug to enter into the bloodstream through interstitial fluid. It’s this fluid that circulates through the body like a flowing river and disperses the medication rapidly, twice as fast as a subcutaneous injection.

Also, because our device targets the skin layer, drug delivery can take place anywhere on the body rather than the five, often overused, sites of subcutaneous injection (abdomen, front of thighs, upper arms).  With a shallow injection, the pressure required to administer the drug can also be minimal.  

These unique benefits of our technology, coupled with premeasured doses indicated by coloured caps, means the PKA SoftTouch Micro-Needle will have a level of drug dosage accuracy and safety that is currently unavailable on the market.

What does this mean for the users of our device? 

If you’re a diabetic waiting for your insulin to take effect, the wait time could be halved.

In a hospital setting, clinicians could see patients responding to drugs twice as fast. 

This could have a huge impact in the healthcare sector where speed is often a critical factor for a patient’s welfare such as in cases of poisoning on opioids or where a dog has gone into anaphylactic shock.

The device will greatly enhance the quality of life for patients.

Micro-needle Patented Worldwide

In 2007, Dr. Modi and I decided our device was ready to be patented. Our micro-needle had performed incredibly well in recent tests and a patent would grant us a right as the inventor to exclude others from making, selling or using the invention for a period of time. Given the unique features of our technology and the results we were seeing, this was a prudent next step for us.

Gowling WLG, based out of Hamilton, Ontario, is a worldwide patent law company with roots going back to 1887. They have become one of the largest and most respected law firms in Canada and have helped Dr. Modi patent previous inventions. One would be hard-pressed to find a more seasoned firm to help navigate negotiations with the patent examiners of various countries. Proving to be of great value to us, we also discovered their talent in writing a strong patent that would obtain the necessary approvals.

The first item of business was to search for all prior patent science. It was interesting to discover that many earlier patents reviewed over the previous 50 years have tried to enter the skin only. Most were intricate devices that had many parts and were therefore very complicated. Most had complex ways to enter the skin and would be very expensive.

What made our device novel is that we have only nine moving parts to achieve a painless injection into the skin. That is the strength of Dr. Modi’s intellect – to come up with a unique device that can easily and painlessly enter the skin. We drew all the individual parts and gave them to the attorney to draw up in “Patent Configuration.” Extensive discussions took place to describe the function and movement of each component. The material was selected for each piece as we moved through our testing. 

After multiple write-ups, a final draft was completed. We chose to apply to Canada and U.S. patent departments first. Formal submittals were made and it took several years to finalize our efforts with the two countries. Once our claims were found to be sound and we obtained conditional approval, the patents were then publicized to see if any other country could object. In 2009, our claims were approved and we were issued with our first patent in Canada, followed by the U.S. in 2013. This proved that our patents were strong, and we could now proceed with patents in other countries.  

Since then, the PKA SoftTouch Micro-Needle has been granted a total of 21 patents in the following countries: Canada, United States, South Africa, New Zealand, Australia, Japan, India, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Poland, Spain, Sweden, Switzerland, United Kingdom. We also have patents pending in Argentina and Brazil. 

PKA SoftTouch Corp. is a leading-edge research and development company that has created a unique, revolutionary and proprietary device; the PKA SoftTouch Micro-Needle. This revolutionary device will replace the ubiquitous syringe in drug applications for the pharmaceutical, health care and veterinary industries by offering a precise, pain-free medication delivery in a safe and effective manner. 

To learn more, please visit www.pkasofttouch.com. Watch the video and subscribe for updates for the upcoming equity crowdfunding campaign – your opportunity to become a shareholder of our company.